Bavarian Nordic launches chikungunya vaccine Vimkunya in the UK

Tackle the challenges you're facing in oral solid dosage (OSD) manufacturing

The US-based pharmaceutical production firm has launched to pursue 25+ new products over next two years, with a differentiated business model to ensure supply chain resiliency through an established manufacturing partner network

In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced